MiR99a modulates MMP7 and MMP13 to regulate invasiveness of Kaposi’s sarcoma

Tumor Biology

Volumn 35, Issue 12, 2014, Pages 12567-12573

  Zhang, Jun ^a   Wang, Shan ^a   Lu, Linya ^a   Wei, GuangHui ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Kaposi s sarcoma; MMP13; MMP7; MMP9

Indexed keywords

COLLAGENASE 3; GELATINASE B; MATRILYSIN; MICRORNA; MICRORNA 99A; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; MESSENGER RNA; MIRN99 MICRORNA, HUMAN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE CONTROL; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPOSI SARCOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; WESTERN BLOTTING; GENE EXPRESSION; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

CELL LINE, TUMOR; GENE EXPRESSION; HUMANS; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RNA INTERFERENCE; RNA, MESSENGER; SARCOMA, KAPOSI; SIGNAL TRANSDUCTION;

EID: 84925286503     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2577-6     Document Type: Article

References (17)

1. Antman K, Chang Y. Kaposi’s sarcoma. N Engl J Med. 2000;342:1027–38.
2. Ganem D. KSHV infection and the pathogenesis of Kaposi’s sarcoma. Annu Rev Pathol. 2006;1:273–96.
3. Wong EL, Damania B. Linking KSHV to human cancer. Curr Oncol Rep. 2005;7:349–56.
4. Ganem D. KSHV and Kaposi’s sarcoma: the end of the beginning? Cell. 1997;91:157–60.
5. Strongin AY. Mislocalization and unconventional functions of cellular MMPs in cancer. Cancer Metastasis Rev. 2006;25:87–98.
6. Overall CM, Dean RA. Degradomics: Systems biology of the protease web. Pleiotropic roles of MMPs in cancer. Cancer Metastasis Rev. 2006;25:69–75.
7. Yana I, Seiki M. MT-MMPs play pivotal roles in cancer dissemination. Clin Exp Metastasis. 2002;19:209–15.
8. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood). 2006;231:20–7.
9. Koskensalo S, Mrena J, Wiksten JP, Nordling S, Kokkola A, Hagstrom J, et al. MMP-7 overexpression is an independent prognostic marker in gastric cancer. Tumour Biol. 2010;31:149–55.
10. Li Z, Zhang D, Zhang H, Miao Z, Tang Y, Sun G, et al. Prediction of peritoneal recurrence by the MRNA level of CEA and MMP-7 in peritoneal lavage of gastric cancer patients. Tumour Biol. 2014;35:3463–70.
11. St-Pierre Y, Couillard J, Van Themsche C. Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases. Expert Opin Ther Targets. 2004;8:473–89.
12. Balbin M, Pendas AM, Uria JA, Jimenez MG, Freije JP, Lopez-Otin C. Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors. APMIS. 1999;107:45–53.
13. Di Leva G, Croce CM. MiRNA profiling of cancer. Curr Opin Genet Dev. 2013;23:3–11.
14. Pereira DM, Rodrigues PM, Borralho PM, Rodrigues CM. Delivering the promise of miRNA cancer therapeutics. Drug Discov Today. 2013;18:282–9.
15. Marshall V, Martro E, Labo N, Ray A, Wang D, Mbisa G, et al. Kaposi sarcoma (KS)-associated herpesvirus microRNA sequence analysis and KS risk in a European AIDS-KS case control study. J Infect Dis. 2010;202:1126–35.
16. O’Hara AJ, Wang L, Dezube BJ, Harrington Jr WJ, Damania B, Dittmer DP. Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma. Blood. 2009;113:5938–41.
17. Sullivan CS. High conservation of Kaposi sarcoma–associated herpesvirus microRNAs implies important function. J Infect Dis. 2007;195:618–20.